Decoy Therapeutics, based in Cambridge, Massachusetts, is a pharmaceutical company focused on leveraging artificial intelligence to develop treatments for respiratory diseases. With significant backing from major investors including Johnson & Johnson and the Bill and Melinda Gates Foundation, Decoy Therapeutics is poised to advance multiple drug candidates that address significant unmet needs in numerous therapeutic areas.